293 related articles for article (PubMed ID: 17218080)
1. Effects of various pesticides on human 5alpha-reductase activity in prostate and LNCaP cells.
Lo S; King I; Alléra A; Klingmüller D
Toxicol In Vitro; 2007 Apr; 21(3):502-8. PubMed ID: 17218080
[TBL] [Abstract][Full Text] [Related]
2. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
Lazier CB; Thomas LN; Douglas RC; Vessey JP; Rittmaster RS
Prostate; 2004 Feb; 58(2):130-44. PubMed ID: 14716738
[TBL] [Abstract][Full Text] [Related]
3. Aromatic esters of progesterone as 5alpha-reductase and prostate growth inhibitors.
Bratoeff E; Segura T; Recillas S; Carrizales E; Palacios A; Heuze I; Cabeza M
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):655-62. PubMed ID: 18825535
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
5. Novel C-6 substituted and unsubstituted pregnane derivatives as 5alpha-reductase inhibitors and their effect on hamster flank organs diameter size.
Cabeza M; Zambrano A; Heuze I; Carrizales E; Palacios A; Segura T; Valencia N; Bratoeff E
Steroids; 2009 Oct; 74(10-11):793-802. PubMed ID: 19406144
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of progesterone derivatives as 5alpha-reductase inhibitors, and their effect on hamster prostate weight.
Bratoeff E; Zambrano A; Heuze I; Palacios A; Ramírez D; Cabeza M
J Enzyme Inhib Med Chem; 2010 Jun; 25(3):306-11. PubMed ID: 19874206
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
[TBL] [Abstract][Full Text] [Related]
8. Modulation of aromatase activity and mRNA by various selected pesticides in the human choriocarcinoma JEG-3 cell line.
Laville N; Balaguer P; Brion F; Hinfray N; Casellas C; Porcher JM; Aït-Aïssa S
Toxicology; 2006 Nov; 228(1):98-108. PubMed ID: 16996190
[TBL] [Abstract][Full Text] [Related]
9. Effects of dutasteride on prostate carcinoma primary cultures: a comparative study with finasteride and MK386.
Festuccia C; Gravina GL; Muzi P; Pomante R; Angelucci A; Vicentini C; Bologna M
J Urol; 2008 Jul; 180(1):367-72. PubMed ID: 18499161
[TBL] [Abstract][Full Text] [Related]
10. New 5alpha-reductase inhibitors: in vitro and in vivo effects.
Pérez-Ornelas V; Cabeza M; Bratoeff E; Heuze I; Sánchez M; Ramírez E; Naranjo-Rodríguez E
Steroids; 2005 Mar; 70(3):217-24. PubMed ID: 15763601
[TBL] [Abstract][Full Text] [Related]
11. An overview on 5alpha-reductase inhibitors.
Aggarwal S; Thareja S; Verma A; Bhardwaj TR; Kumar M
Steroids; 2010 Feb; 75(2):109-53. PubMed ID: 19879888
[TBL] [Abstract][Full Text] [Related]
12. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line.
Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM
Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of 5alpha -reductase type I in LNCaP cells from the roots of Angelica koreana.
Seo EK; Kim KH; Kim MK; Cho MH; Choi E; Kim K; Mar W
Planta Med; 2002 Feb; 68(2):162-3. PubMed ID: 11859469
[TBL] [Abstract][Full Text] [Related]
14. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
Day JM; Tutill HJ; Foster PA; Bailey HV; Heaton WB; Sharland CM; Vicker N; Potter BV; Purohit A; Reed MJ
Mol Cell Endocrinol; 2009 Mar; 301(1-2):251-8. PubMed ID: 18786604
[TBL] [Abstract][Full Text] [Related]
15. The antigonadotropic action of testosterone but not 7alpha-methyl-19-nortestosterone is attenuated through the 5alpha-reductase pathway in the castrated male rat pituitary gland.
Bandivdekar AH; Karp R; Sundaram K; Kumar N
J Androl; 2000; 21(2):268-75. PubMed ID: 10714822
[TBL] [Abstract][Full Text] [Related]
16. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.
Lou YR; Murtola T; Tuohimaa P
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):151-7. PubMed ID: 15862960
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of somatic steroid 5alpha-reductase (SRD5A2) mutations in human prostate cancer tissue.
Makridakis N; Akalu A; Reichardt JK
Oncogene; 2004 Sep; 23(44):7399-405. PubMed ID: 15326487
[TBL] [Abstract][Full Text] [Related]
18. 5alpha-reductase isozymes and androgen actions in the prostate.
Zhu YS; Imperato-McGinley JL
Ann N Y Acad Sci; 2009 Feb; 1155():43-56. PubMed ID: 19250191
[TBL] [Abstract][Full Text] [Related]
19. Testosterone-dependent restoration of spermatogenesis in adult rats is impaired by a 5alpha-reductase inhibitor.
O'Donnell L; Pratis K; Stanton PG; Robertson DM; McLachlan RI
J Androl; 1999; 20(1):109-17. PubMed ID: 10100481
[TBL] [Abstract][Full Text] [Related]
20. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
Yang Q; Titus MA; Fung KM; Lin HK
J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
